Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sorlandet Hospital HF |
---|---|
Information provided by: | Sorlandet Hospital HF |
ClinicalTrials.gov Identifier: | NCT00138801 |
The aim of this study is to compare parenteral ceftriaxone and oral doxycycline in the treatment of neuroborreliosis in a randomized controlled trial.
Condition | Intervention | Phase |
---|---|---|
Lyme Neuroborreliosis |
Drug: Ceftriaxone Drug: Doxycycline |
Phase III |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Double-Blind, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis. A Randomized Double-Blind Comparison |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Neurological symptoms and/or findings consistent with neuroborreliosis and at least one of the following fulfilled:
Exclusion Criteria:
Contact: Unn Ljøstad, MD | ++4738073910 | unn.ljostad@sshf.no |
Norway, Vest-Agder | |
Sørlandet Sykehus HF | Recruiting |
Kristiansand, Vest-Agder, Norway, 4633 | |
Contact: Svein Gunnar Gundersen, MD, PhD ++4738073000 s.g.gundersen@sshf.no | |
Principal Investigator: Unn Ljøstad, MD |
Study Chair: | Åse Mygland, MD, PhD | Sorlandet Sykehus HF |
Study ID Numbers: | SSHF70204 |
Study First Received: | August 29, 2005 |
Last Updated: | December 14, 2005 |
ClinicalTrials.gov Identifier: | NCT00138801 |
Health Authority: | Norway: Directorate for Health and Social Affairs |
Neuroborreliosis |
Bacterial Infections Central Nervous System Infections Borrelia Infections Borreliosis Lyme Disease Central Nervous System Diseases |
Lyme Neuroborreliosis Ceftriaxone Doxycycline Tick-Borne Diseases Gram-Negative Bacterial Infections |
Antimalarials Anti-Infective Agents Anti-Bacterial Agents Antiparasitic Agents Antiprotozoal Agents |
Spirochaetales Infections Therapeutic Uses Nervous System Diseases Central Nervous System Bacterial Infections Pharmacologic Actions |